rs142704524

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_178452.6(DNAAF1):​c.352+17G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0167 in 1,567,880 control chromosomes in the GnomAD database, including 280 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 25 hom., cov: 33)
Exomes 𝑓: 0.017 ( 255 hom. )

Consequence

DNAAF1
NM_178452.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.515

Publications

0 publications found
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-84150359-G-C is Benign according to our data. Variant chr16-84150359-G-C is described in ClinVar as Benign. ClinVar VariationId is 262952.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0139 (2124/152326) while in subpopulation NFE AF = 0.0198 (1346/68040). AF 95% confidence interval is 0.0189. There are 25 homozygotes in GnomAd4. There are 1033 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF1NM_178452.6 linkc.352+17G>C intron_variant Intron 3 of 11 ENST00000378553.10 NP_848547.4 Q8NEP3-1A0A140VJN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF1ENST00000378553.10 linkc.352+17G>C intron_variant Intron 3 of 11 1 NM_178452.6 ENSP00000367815.5 Q8NEP3-1
DNAAF1ENST00000567918.5 linkn.352+17G>C intron_variant Intron 3 of 6 1 ENSP00000455154.1 H3BP51
DNAAF1ENST00000563093.5 linkn.352+17G>C intron_variant Intron 3 of 10 2 ENSP00000457373.1 Q8NEP3-3
DNAAF1ENST00000570298.5 linkn.506+17G>C intron_variant Intron 3 of 10 2

Frequencies

GnomAD3 genomes
AF:
0.0140
AC:
2125
AN:
152208
Hom.:
25
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00331
Gnomad AMI
AF:
0.103
Gnomad AMR
AF:
0.0145
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.0225
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0198
Gnomad OTH
AF:
0.0191
GnomAD2 exomes
AF:
0.0133
AC:
3339
AN:
250818
AF XY:
0.0136
show subpopulations
Gnomad AFR exome
AF:
0.00346
Gnomad AMR exome
AF:
0.00940
Gnomad ASJ exome
AF:
0.0110
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0237
Gnomad NFE exome
AF:
0.0188
Gnomad OTH exome
AF:
0.0126
GnomAD4 exome
AF:
0.0170
AC:
24097
AN:
1415554
Hom.:
255
Cov.:
25
AF XY:
0.0167
AC XY:
11817
AN XY:
707422
show subpopulations
African (AFR)
AF:
0.00342
AC:
111
AN:
32500
American (AMR)
AF:
0.0101
AC:
449
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.0117
AC:
302
AN:
25894
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39440
South Asian (SAS)
AF:
0.00416
AC:
355
AN:
85298
European-Finnish (FIN)
AF:
0.0241
AC:
1287
AN:
53356
Middle Eastern (MID)
AF:
0.00808
AC:
46
AN:
5692
European-Non Finnish (NFE)
AF:
0.0193
AC:
20637
AN:
1069852
Other (OTH)
AF:
0.0155
AC:
910
AN:
58848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1105
2211
3316
4422
5527
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0139
AC:
2124
AN:
152326
Hom.:
25
Cov.:
33
AF XY:
0.0139
AC XY:
1033
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00330
AC:
137
AN:
41564
American (AMR)
AF:
0.0145
AC:
222
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00269
AC:
13
AN:
4834
European-Finnish (FIN)
AF:
0.0225
AC:
239
AN:
10608
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0198
AC:
1346
AN:
68040
Other (OTH)
AF:
0.0189
AC:
40
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
108
217
325
434
542
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0166
Hom.:
6
Bravo
AF:
0.0126
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 13 Benign:1
Oct 03, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
4.4
DANN
Benign
0.27
PhyloP100
0.52
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142704524; hg19: chr16-84183964; API